Protein Fv: An endogenous immunoglobulin superantigen and superallergen

Chemical Immunology and Allergy

Volumn 93, Issue 1, 2007, Pages 58-76

  Bouvet, Jean Pierre ^a   Marone, Gianni ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN M; INTERLEUKIN 4; PROTEIN FV; SUPERANTIGEN; TRYPTASE; UNCLASSIFIED DRUG; ALLERGEN; FV PROTEIN, HUMAN; LYMPHOKINE; SIALOGLYCOPROTEIN;

ALLERGIC DISEASE; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; BASOPHIL; BINDING AFFINITY; BINDING SITE; BODY FLUID; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CELL ACTIVATION; COMPLEMENT ACTIVATION; CYTOKINE RELEASE; DISEASE ASSOCIATION; HEPATITIS B; HEPATITIS C; HISTAMINE RELEASE; HUMAN; IMMUNOGLOBULIN PRODUCTION; LIVER; MAST CELL; MYOCARDITIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; BIOSYNTHESIS; HEART MUSCLE; IMMUNOLOGY; PHYSIOLOGY; REVIEW;

ALLERGENS; BASOPHILS; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-4; LYMPHOKINES; MAST CELLS; MYOCARDIUM; SIALOGLYCOPROTEINS; SUPERANTIGENS;

EID: 34249667658     PISSN: 16602242     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000100858     Document Type: Article

References (75)

1. Bouvet JP, Pirès R, Lunel-Fabiani F, Crescenzo-Chaigne B, Maillard P, Valla D, Opolon P, Pillot J: Protein F. A novel F(ab -binding factor, present in normal liver, and largely released in the digestive tract during hepatitis. J Immunol 1990;145:1176-1180.
2. Bouvet JP, Pillot J: Letter to the editor. J Immunol 1990;145:3944.
3. H-binding specificity of human protein Fv. Scand J Immunol 1991;33:381-386.
4. Bouvet JP, Pirès R, Quan CP: Protein Fv (Fv fragment binding protein): A mucosal human super-antigen reacting with normal immunoglobulins; in Zouali M (ed): Human B Cell Superantigens. Austin, RG Landes Company, 1996, pp 179-188.
5. Sharma MD, Maillard P, Vrati S, Mukherjee R, Rajagopalan MS, Poynard T, Talwar GP, Pillot J: Serial passage of west-European sporadic non-A non-B hepatitis in rhesus monkeys by inoculation with fecal extracts. J Med Virol 1990;30:36-41.
6. Bouvet JP, Pirès R, Iscaki S, Pillot J: Nonimmune macromolecular complexes of Ig in human gut lumen. Probable enhancement of antibody functions. J Immunol 1993;151:2562-2572.
7. Bouvet JP, Pirès R, Charlemagne J, Pillot J, Iscaki S: Non-immune binding of human protein Fv to immunoglobulins from various mammalian and non-mammalian species. Scand J Immunol 1991;34: 491-496.
8. Woof JM, Kerr MA: The function of immunoglobulin A in immunity. J Pathol 2006;208:270-282.
9. Brandtzaeg P, Halstensen TS, Kett K, Krajci P, Kvale D, Rognum TO, Scott H, Sollid LM: Immunobiology and immunopathology of human gut mucosa: humoral immunity and intraepithelial lymphocytes. Gastroenterology 1989;97:1562-1584.
10. Kilian M, Mestecky J, Russell MW: Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases. Microbiol Rev 1988;52:296-303.
11. Thurman JM, Holers VM: The central role of the alternative complement pathway in human disease. J Immunol 2006;176:1305-1310.
12. Ruffet E, Pirès R, Pillot J, Bouvet JP: Activation of the classical pathway of complement by non-immune complexes of immunoglobulins with human protein Fv (Fv fragment-binding protein). Scand J Immunol 1994;40:359-362.
13. Quan CP, Berneman A, Pirès R, Avrameas S, Bouvet JP: Natural polyreactive secretory immunoglobulin A autoantibodies as a possible barrier to infection in humans. Infect Immun 1997;65:3997-4004.
14. Silverman GJ: B-cell superantigens. Immunol Today 1997;18:379-386.
15. Bueno C, Criado G, McCormick JK, Madrenas J: T cell signaling induced by bacterial superantigens; in Marone G (ed): Superantigens and Superallergens. Chem Immunol Allergy. Basel, Karger, 2007, vol 73, pp 161-180.
16. Thomas D, Chou S, Dauwalder O, Lina G: Diversity in Staphylococcus aureus enterotoxins; in Marone G (ed): Superantigens and Superallergens. Chem Immunol Allergy. Basel, Karger, 2007, vol 73, pp 24-41.
17. Zouali M: B cell superantigens subvert innate functions of B cells; in Marone G (ed): Superantigens and Superallergens, Chem Immunol Allergy. Basel, Karger, 2007, vol 73, pp 92-105.
18. Graille M, Stura EA, Corper AL, Sutton BJ, Taussig MJ, Charbonnier JB, Silverman GJ: Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity. Proc Natl Acad Sci USA 2000;97:5399-5404.
19. Inganas M, Johansson SG, Bennich HH: Interaction of human polyclonal IgE and IgG from different species with protein A from Staphylococcus aureus: Demonstration of protein-A-reactive sites located in the Fab′2 fragment of human IgG. Scand J Immunol 1980;12:23-31.
20. Townsley-Fuchs J, Neshat MS, Margolin DH, Braun J, Goodglick L: HIV-1 gp120: A novel viral B cell superantigen. Int Rev Immunol 1997;14:325-338.
21. Björck L: Protein L. A novel bacterial cell wall protein with affinity for Ig L chains. J Immunol 1988;140:1194-1197.
22. Silverman GJ, Pirès R, Bouvet JP: An endogenous sialoprotein and a bacterial B cell superantigen compete in their VH family-specific binding interactions with human Igs. J Immunol 1996;157: 4496-4502.
23. Silverman GJ, Roben P, Bouvet JP, Sasano M: Superantigen properties of a human sialoprotein involved in gut-associated immunity. J Clin Invest 1995;96:417-426.
24. Marone G, Rossi FW, Bova M, Detoraki A, Liccardo B, Petraroli A: Superallergens: A novel mechanism of IgE-mediated activation of human basophils and mast cells. Clin Exp All Rev 2004;4: 64-75.
25. Marone G, Spadaro G, Liccardo B, Rossi FW, D'Orio C, Detoraki A: Superallergens: A new mechanism of immunologic activation of human basophils and mast cells. Inflamm Res 2006;55: S25-S27.
26. Marone G, Lichtenstein LM, Galli SJ: Mast Cells and Basophils. San Diego, Academic Press, 2000.
27. de Paulis A, Minopoli G, Arbustini E, de Crescenzo G, Dal Piaz F, Pucci P, Russo T, Marone G: Stem cell factor is localized in, released from, and cleaved by human mast cells. J Immunol 1999;163:2799-2808.
28. Marone G, Triggiani M, Genovese A, de Paulis A: Role of human mast cells and basophils in bronchial asthma. Adv Immunol 2005;88:97-160.
29. Casolaro V, Galeone D, Giacummo A, Sanduzzi A, Melillo G, Marone G: Human basophil/mast cell releasability. 5. Functional comparisons of cells obtained from peripheral blood, lung parenchyma, and bronchoalveolar lavage in asthmatics. Am Rev Respir Dis 1989;139:1375-1382.
30. MacGlashan D Jr, White JM, Huang SK, Ono SJ, Schroeder JT, Lichtenstein LM: Secretion of IL-4 from human basophils. The relationship between IL-4mRNA and protein in resting and stimulated basophils. J Immunol 1994;152:3006-3016.
31. Patella V, Marinò I, Lampärter B, Arbustini E, Adt M, Marone G: Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. J Immunol 1995;154: 2855-2865.
32. H3 region of IgE. J Immunol 1998;161:5647-5655.
33. Lichtenstein LM, Kagey-Sobotka A, White JM, Hamilton RG: Anti-human IgG causes basophil histamine release by acting on IgG-IgE complexes bound to IgE receptors. J Immunol 1992;148: 3929-3936.
34. MaRone G: Asthma: recent advances. Immunol Today 1998;19:5-9.
35. Lauer GM, Walker BD: Hepatitis C virus infection. N Engl J Med 2001;345:41-52.
36. Lee WM: Hepatitis B virus infection. N Engl J Med 1997;337:1733-1745.
37. Segool RA, Lejtenyi C, Taussig LM: Articular and cutaneous prodromal manifestations of viral hepatitis. J Pediatr 1975;87:709-712.
38. Popp JW Jr, Harrist TJ, Dienstag JL, Bhan AK, Wands JR, LaMont JT, Mihm MC Jr: Cutaneous vasculitis associated with acute and chronic hepatitis. Arch Intern Med 1981;141:623-629.
39. Miadonna A, Tedeschi A, Leggieri E, Invernizzi F, Zanussi C: Basophil activation in idiopathic mixed cryoglobulinemia. J Clin Immunol 1982;2:309-313.
40. Vaida GA, Goldman MA, Bloch KJ: Testing for hepatitis B virus in patients with chronic urticaria and angioedema. J Allergy Clin Immunol 1983;72:193-198.
41. Patella V, Bouvet JP, Marone G: Protein Fv produced during viral hepatitis is a novel activator of human basophils and mast cells. J Immunol 1993;151:5685-5698.
42. Del Prete G, Maggi E, Parronchi P, Chretien I, Tiri A, Macchia D, Ricci M, Banchereau J, De Vries J, Romagnani S: IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J Immunol 1988;140:4193-4198.
43. Peters CJ, Johnson KM: Serum immunoglobulin levels in Australia antigen positive and Australia antigen negative hepatitis. Clin Exp Immunol 1972;11:381-391.
44. Van Epps E, Husby G, Williams RC Jr, Strickland RG: Liver disease - a prominent cause of serum IgE elevation. Clin Exp Immunol 1976;23:444-450.
45. Bell H: Cardiac manifestations of viral hepatitis. JAMA 1971;218:387-391.
46. Nagaratnam N, Gunawardene KR, De Silva DP: Myocardial involvement in infectious hepatitis. Postgrad Med J 1971;47:785-788.
47. Ursell PC, Habib A, Sharma P, Mesa-Tejada R, Lefkowitch JH, Fenoglio JJ Jr: Hepatitis B virus and myocarditis. Hum Pathol 1984;15:481-484.
48. Kanda T, Kobayashi I, Suzuki T, Murata K, Radio SJ, McManus BM: Elevation of ALT to AST ratio in patients with enteroviral myocarditis. J Med 1995;26:153-162.
49. Agnello V, Chung RT, Kaplan LM: A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327:1490-1495.
50. Dammacco F, Sansonno D: Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia. Clin Exp Immunol 1992;87:352-356.
51. Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, Franklin EC: Mixed cryoglobulinemia: Clinical aspects and long-term follow-up of 40 patients. Am J Med 1980;69:287-308.
52. Bankl HC, Radaszkiewicz T, Klappacher GW, Glogar D, Sperr WR, Grossschmidt K, Bankl H, Lechner K, Valent P: Increase and redistribution of cardiac mast cells in auricular thrombosis. Possible role of kit ligand. Circulation 1995;91:275-283.
53. Kalsner S, Richards R: Coronary arteries of cardiac patients are hyperreactive and contain stores of amines: A mechanism for coronary spasm. Science 1984;223:1435-1437.
54. Kaartinen M, Penttila A, Kovanen PT: Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation 1994;90: 1669-1678.
55. Estensen RD: EosinopAilic myocarditis: a role for mast cells? Arch Pathol Lab Med 1984;108: 358-359.
56. Patella V, de Crescenzo G, Marinò I, Genovese A, Adt M, Gleich GJ, Marone G: Eosinophil granule proteins activate human heart mast cells. J Immunol 1996;157:1219-1225.
57. Patella V, Marinò I, Arbustini E, Lamparter-Schummert B, Verga L, Adt M, Marone G: Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. Circulation 1998;97:971-978.
58. Genovese A, Borgia G, Bouvet JP, Detoraki A, de Paulis A, Piazza M, Marone G: Protein Fv produced during viral hepatitis is an endogenous immunoglobulin superantigen activating human heart mast cells. Int Arch Allergy Immunol 2003;132:336-345.
59. 2, that inhibits platelet aggregation and constricts blood vessels. J Biol Chem 1985;260:14621-14625.
60. 4 in man. Int J Clin Lab Res 1997;27:178-184.
61. Samuelsson B: The discovery of the leukotrienes. Am J Respir Crit Care Med 2000;161:S2-S6.
62. 2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 2001;193:255-261.
63. Genovese A, Bouvet JP, Florio G, Lamparter-Schummert B, Björck L, Marone G: Bacterial immunoglobulin superantigen proteins A and L activate human heart mast cells by interacting with immunoglobulin E. Infect Immun 2000;68:5517-5524.
64. Vigorito C, Poto S, Picotti GB, Triggiani M, Marone G: Effect of activation of the H1 receptor on coronary hemodynamics in man. Circulation 1986;73:1175-1182.
65. Schwartz LB, Kawahara MS, Hugli TE, Vik D, Fearon DT, Austen KF: Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase. J Immunol 1983;130:1891-1895.
66. H3 region of IgE to induce cytokine secretion from human basophils. Int Arch Allergy Immunol 1999;118:197-199.
67. Willson RA: Extrahepatic manifestations of chronic viral hepatitis. Am J Gastroenterol 1997;92: 3-17.
68. Matsumori A, Matoba Y, Nishio R, Shioi T, Ono K, Sasayama S: Detection of hepatitis C virus RNA from the heart of patients with hypertrophic cardiomyopathy. Biochem Biophys Res Commun 1996;222:678-682.
69. Matsumori A, Yutani C, Ikeda Y, Kawai S, Sasayama S: Hepatitis C virus from the hearts of patients with myocarditis and cardiomyopathy. Lab Invest 2000;80:1137-1142.
70. Hawkins RA, Claman HN, Clark RA, Steigerwald JC: Increased dermal mast cell populations in progressive systemic sclerosis: A link in chronic fibrosis? Ann Intern Med 1985;102:182-186.
71. Broide DH, Smith CM, Wasserman SI: Mast cells and pulmonary fibrosis. Identification of a histamine releasing factor in bronchoalveolar lavage fluid. J Immunol 1990;145:1838-1844.
72. de Paulis A, Valentini G, Spadaro G, Lupoli S, Tirri G, Marone G: Human basophil releasability. VIII. Increased basophil releasability in patients with scleroderma. Arthritis Rheum 1991;34: 1289-1296.
73. Hatamochi A, Fujiwara K, Ueki H: Effects of histamine on collagen synthesis by cultured fibroblasts derived from guinea pig skin. Arch Dermatol Res 1985;277:60-64.
74. Ruoss SJ, Hartmann T, Caughey GH: Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 1991;88:493-499.
75. Pennington DW, Lopez AR, Thomas PS, Peck C, Gold WM: Dog mastocytoma cells produce transforming growth factor beta 1. J Clin Invest 1992;90:35-41.